Merck
MRK
#55
Rank
C$374.94 B
Marketcap
C$150.11
Share price
1.78%
Change (1 day)
6.63%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): C$10.67

According to Merck's latest financial reports the company's current EPS (TTM) is C$10.34. In 2024 the company made an earnings per share (EPS) of C$9.20 an increase over its 2023 EPS that were of C$0.21.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$10.6716.01%
2024C$9.204308.46%
2023C$0.21-97.32%
2022C$7.8010.92%
2021C$7.0384.68%
2020C$3.81-27.2%
2019C$5.2363.44%
2018C$3.20151.11%
2017C$1.27-54.58%
2016C$2.8130.21%
2015C$2.15-61.99%
2014C$5.67180.51%
2013C$2.02-31.82%
2012C$2.966.62%
2011C$2.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$14.21 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.02-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$2.34-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$10.97 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$27.93 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$17.74 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$5.04-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$4.04-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.90-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$0.86-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel